<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=1372388" created="05/02/2007" creator="Junko Matsuura"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>1372388</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">A <term id="T1" lex="lymphoid_cell-specific_nuclear_factor" sem="Protein_molecule">lymphoid cell-specific nuclear factor</term> containing <term id="T2" lex="c-Rel-like_protein" sem="Protein_family_or_group">c-Rel-like proteins</term> preferentially interacts with <term id="T3" lex="interleukin-6_kappa_B-related_motif" sem="DNA_domain_or_region">interleukin-6 kappa B-related motifs</term> whose activities are repressed in <term id="T4" lex="lymphoid_cell" sem="Cell_natural">lymphoid cells</term>.</sentence>
<event id="E1">
<type class="Binding"/>
<theme idref="T1"/>
<theme idref="T3"/>
<clue>A lymphoid cell-specific nuclear factor containing c-Rel-like proteins preferentially <clueType>interacts</clueType> <linkTheme>with</linkTheme> interleukin-6 kappa B-related motifs whose activities are repressed in lymphoid cells.</clue>
</event>
<event KT="Fact" id="E2">
<type class="Negative_regulation"/>
<theme idref="T3"/>
<clue>A lymphoid cell-specific nuclear factor containing c-Rel-like proteins preferentially interacts with interleukin-6 kappa B-related motifs whose activities are <clueType>repressed</clueType> <clueLoc>in lymphoid cells</clueLoc>.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The <term id="T5" lex="proto-oncoprotein_c-Rel" sem="Protein_molecule">proto-oncoprotein c-Rel</term> is a member of the <term id="T6" lex="nuclear_factor_kappa_B_transcription_factor_family" sem="Protein_family_or_group">nuclear factor kappa B transcription factor family</term>, which includes the <term id="T7" lex="p50" sem="Protein_molecule">p50</term> and <term id="T8" lex="p65_subunit" sem="Protein_molecule">p65 subunits</term> of <term id="T9" lex="nuclear_factor_kappa_B" sem="Protein_molecule">nuclear factor kappa B</term>.</sentence>
<sentence id="S3">We show here that <term id="T10" lex="c-Rel" sem="Protein_molecule">c-Rel</term> binds to <term id="T11" lex="kappa_B_site" sem="DNA_domain_or_region">kappa B sites</term> as <term id="T12" lex="homodimer" sem="Protein_complex">homodimers</term> as well as <term id="T13" lex="heterodimer" sem="Protein_molecule">heterodimers</term> with <term id="T14" lex="p50" sem="Protein_molecule">p50</term>.</sentence>
<event KT="Analysis" id="E3">
<type class="Binding"/>
<theme idref="T10"/>
<theme idref="T11"/>
<clue>We <clueKT>show</clueKT> here that c-Rel <clueType>binds</clueType> <linkTheme>to</linkTheme> kappa B sites as homodimers as well as heterodimers with p50.</clue>
</event>
<event KT="Other" id="E4">
<type class="Binding"/>
<theme idref="T10"/>
<clue>We show here that c-Rel binds to kappa B sites <clueType>as homodimers</clueType> as well as heterodimers with p50.</clue>
</event>
<event KT="Other" id="E5">
<type class="Binding"/>
<theme idref="T10"/>
<theme idref="T14"/>
<clue>We show here that c-Rel binds to kappa B sites <clueType>as</clueType> homodimers as well as <clueType>heterodimers</clueType> <linkTheme>with</linkTheme> p50.</clue>
</event>
<sentence id="S4">These <term id="T15" lex="homodimer" sem="Protein_complex">homodimers</term> and <term id="T16" lex="heterodimers" sem="Protein_complex">heterodimers</term> show distinct <term id="A1" sem="DNA_molecule">DNA</term>-binding specificities and affinities for various <term id="T17" lex="kappa_B_motifs" sem="DNA_domain_or_region">kappa B motifs</term>.</sentence>
<event KT="Analysis" id="E6">
<type class="Binding"/>
<theme idref="T10" idref1="T15"/>
<theme idref="A1"/>
<clue><corefTheme idref1="T10">These</corefTheme> homodimers and heterodimers <clueKT>show</clueKT> distinct DNA-<clueType>binding specificities</clueType> and affinities for various kappa B motifs.</clue>
</event>
<event KT="Analysis" id="E7">
<type class="Binding"/>
<theme idref="T10" idref1="T16"/>
<theme idref="A1"/>
<clue><corefTheme idref1="T10">These</corefTheme> homodimers and heterodimers <clueKT>show</clueKT> distinct DNA-<clueType>binding specificities</clueType> and affinities for various kappa B motifs.</clue>
</event>
<event KT="Analysis" id="E8">
<type class="Binding"/>
<theme idref="T10" idref1="T15"/>
<theme idref="T17"/>
<clue><corefTheme idref1="T10">These</corefTheme> homodimers and heterodimers <clueKT>show</clueKT> distinct DNA-binding specificities and <clueType>affinities</clueType> <linkTheme>for</linkTheme> various kappa B motifs.</clue>
</event>
<event KT="Analysis" id="E9">
<type class="Binding"/>
<theme idref="T10" idref1="T16"/>
<theme idref="T17"/>
<clue><corefTheme idref1="T10">These</corefTheme> homodimers and heterodimers <clueKT>show</clueKT> distinct DNA-binding specificities and <clueType>affinities</clueType> <linkTheme>for</linkTheme> various kappa B motifs.</clue>
</event>
<sentence id="S5">In particular, the <term id="T18" lex="c-Rel_homodimer" sem="Protein_molecule"><term id="T19" lex="c-Rel" sem="Protein_molecule">c-Rel</term> homodimer</term> has a high affinity for <term id="T20" lex="interleukin-6" sem="Protein_molecule"><term id="T21" lex="interleukin-6_site" sem="DNA_domain_or_region">interleukin-6</term></term> (<term id="T22" lex="IL-6" sem="Protein_molecule">IL-6</term>) and <term id="T23" lex="beta_interferon_kappa_B_site" sem="DNA_domain_or_region">beta interferon <term id="T24" lex="kappa_B_site" sem="DNA_domain_or_region">kappa B sites</term></term>.</sentence>
<event Manner="High" id="E10">
<type class="Binding"/>
<theme idref="T18"/>
<theme idref="T21" idref1="T24"/>
<clue>In particular, the c-Rel homodimer <clueType>has</clueType> a <clueManner>high</clueManner> <clueType>affinity</clueType> <linkTheme>for</linkTheme> interleukin-6 (IL-6) and beta interferon kappa B sites.</clue>
</event>
<event Manner="High" id="E11">
<type class="Binding"/>
<theme idref="T18"/>
<theme idref="T23"/>
<clue>In particular, the c-Rel homodimer <clueType>has</clueType> a <clueManner>high</clueManner> <clueType>affinity</clueType> <linkTheme>for</linkTheme> interleukin-6 (IL-6) and beta interferon kappa B sites.</clue>
</event>
<sentence id="S6">In spite of its association with <term id="T25" lex="p50" sem="Protein_molecule">p50</term> in vitro, however, we found a <term id="T26" lex="lymphoid_cell-specific_nuclear_factor" sem="Protein_family_or_group">lymphoid cell-specific nuclear factor</term> in vivo <term id="A2" sem="Protein_molecule">that contains <term id="T27" lex="c-Rel" sem="Protein_molecule">c-Rel</term> but not <term id="T28" lex="p50_epitope" sem="Protein_domain_or_region"><term id="T29" lex="p50" sem="Protein_molecule">p50</term> epitopes</term></term>; this factor, termed <term id="T30" lex="IL-6_kappa_B_binding_factor_II" sem="Protein_molecule"><term id="T31" lex="IL-6" sem="Protein_molecule">IL-6</term> kappa B binding factor II</term>, appears to contain the <term id="T32" lex="c-Rel_homodimer" sem="Protein_molecule"><term id="T33" lex="c-Rel" sem="Protein_molecule">c-Rel</term> homodimer</term> and preferentially recognizes several <term id="T34" lex="IL-6_kappa_B-related_kappa_B_motif" sem="DNA_domain_or_region"><term id="T35" lex="IL-6" sem="Protein_molecule">IL-6</term> kappa B-related <term id="T36" lex="kappa_B_motifs" sem="DNA_domain_or_region">kappa B motifs</term></term>.</sentence>
<event KT="Analysis" id="E12">
<type class="Binding"/>
<theme idref="T25"/>
<theme idref="T26" idref1="A2"/>
<clue>In spite of <linkTheme>its</linkTheme> <clueType><clueKT>association</clueKT></clueType> <linkTheme>with</linkTheme> p50 in vitro, however, we found a lymphoid cell-specific nuclear factor in vivo that contains c-Rel but not p50 epitopes; this factor, termed IL-6 kappa B binding factor II, appears to contain the c-Rel homodimer and preferentially recognizes several IL-6 kappa B-related kappa B motifs.</clue>
</event>
<event KT="Analysis" id="E13">
<type class="Binding"/>
<theme idref="T25"/>
<theme idref="T30"/>
<clue>In spite of <linkTheme>its</linkTheme> <clueType><clueKT>association</clueKT></clueType> <linkTheme>with</linkTheme> p50 in vitro, however, we found a <corefTheme>lymphoid cell-specific nuclear factor</corefTheme> in vivo that contains c-Rel but not p50 epitopes; this factor, termed IL-6 kappa B binding factor II, appears to contain the c-Rel homodimer and preferentially recognizes several IL-6 kappa B-related kappa B motifs.</clue>
</event>
<event id="E14">
<type class="Binding"/>
<theme idref="T26" idref1="A2"/>
<theme idref="T34"/>
<clue>In spite of its association with p50 in vitro, however, we found a lymphoid cell-specific nuclear factor in vivo that contains c-Rel but not p50 epitopes; this factor, termed IL-6 kappa B binding factor II, appears to contain the c-Rel homodimer and preferentially <clueType>recognizes</clueType> several IL-6 kappa B-related kappa B motifs.</clue>
</event>
<event id="E15">
<type class="Binding"/>
<theme idref="T30"/>
<theme idref="T34"/>
<clue>In spite of its association with p50 in vitro, however, we found a <corefTheme idref1="T30">lymphoid cell-specific nuclear factor</corefTheme> in vivo that contains c-Rel but not p50 epitopes; this factor, termed IL-6 kappa B binding factor II, appears to contain the c-Rel homodimer and preferentially <clueType>recognizes</clueType> several IL-6 kappa B-related kappa B motifs.</clue>
</event>
<sentence id="S7">Although it has been previously shown that the <term id="T37" lex="IL-6_kappa_B_motif" sem="DNA_domain_or_region"><term id="T38" lex="IL-6" sem="Protein_molecule">IL-6</term> kappa B motif</term> functions as a potent <term id="T39" lex="IL-1/tumor_necrosis_factor-responsive_element" sem="DNA_domain_or_region"><term id="A3" sem="Protein_molecule">IL-1</term>/<term id="A4" sem="Protein_molecule">tumor necrosis factor</term>-responsive element</term> in <term id="T40" lex="nonlymphoid_cell" sem="Cell_natural">nonlymphoid cells</term>, its activity was found to be repressed in <term id="T41" lex="lymphoid_cell" sem="Cell_natural">lymphoid cells</term> such as a <term id="T42" lex="Jurkat_T-cell_line" sem="Cell_cultured">Jurkat T-cell line</term>.</sentence>
<event KT="Analysis" Manner="High" Source="Other" id="E16">
<type class="Regulation"/>
<theme idref="T37"/>
<cause idref="A3"/>
<clue>Although it has been <clueSource>previously</clueSource> <clueKT>shown</clueKT> that the IL-6 kappa B motif <clueType>functions as</clueType> a <clueManner>potent</clueManner> IL-1/tumor necrosis factor-<clueType>responsive element</clueType> <clueLoc>in nonlymphoid cells</clueLoc>, its activity was found to be repressed in lymphoid cells such as a Jurkat T-cell line.</clue>
</event>
<event KT="Analysis" Manner="High" Source="Other" id="E17">
<type class="Regulation"/>
<theme idref="T37"/>
<cause idref="A4"/>
<clue>Although it has been <clueSource>previously</clueSource> <clueKT>shown</clueKT> that the IL-6 kappa B motif <clueType>functions as</clueType> a <clueManner>potent</clueManner> IL-1/tumor necrosis factor-<clueType>responsive element</clueType> <clueLoc>in nonlymphoid cells</clueLoc>, its activity was found to be repressed in lymphoid cells such as a Jurkat T-cell line.</clue>
</event>
<event id="E18">
<type class="Negative_regulation"/>
<theme idref="E16"/>
<clue>Although it has been previously shown that the IL-6 kappa B motif functions as a potent IL-1/tumor necrosis factor-responsive element in nonlymphoid cells, <corefTheme>its activity</corefTheme> was <clueKT>found</clueKT> to be <clueType>repressed</clueType> <clueLoc>in lymphoid cells such as a Jurkat T-cell line.</clueLoc></clue>
</event>
<event id="E19">
<type class="Negative_regulation"/>
<theme idref="E17"/>
<clue>Although it has been previously shown that the IL-6 kappa B motif functions as a potent IL-1/tumor necrosis factor-responsive element in nonlymphoid cells, <corefTheme>its activity</corefTheme> was <clueKT>found</clueKT> to be <clueType>repressed</clueType> <clueLoc>in lymphoid cells such as a Jurkat T-cell line.</clueLoc></clue>
</event>
<sentence id="S8">We also present evidence that <term id="T43" lex="IL-6_kappa_B_binding_factor_II" sem="Protein_family_or_group">IL-6 kappa B binding factor II</term> functions as a repressor specific for <term id="T44" lex="IL-6_kappa_B-related_kappa_B_motif" sem="DNA_domain_or_region">IL-6 kappa B-related <term id="T45" lex="kappa_B_motifs" sem="DNA_domain_or_region">kappa B motifs</term></term> in <term id="T46" lex="lymphoid_cell" sem="Cell_natural">lymphoid cells</term>.</sentence>
<event CL="L2" KT="Analysis" id="E20">
<type class="Negative_regulation"/>
<theme idref="T44"/>
<cause idref="T43"/>
<clue>We also present <clueKT><clueCL>evidence</clueCL></clueKT> that IL-6 kappa B binding factor II <clueType>functions as a repressor</clueType> <linkTheme>specific for</linkTheme> IL-6 kappa B-related kappa B motifs <clueLoc>in lymphoid cells</clueLoc>.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
